A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™
Clinical trial NCT06320535 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06320535
- Sponsor
- University of Oxford
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2026-06-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.